Stock Quotes in this Article: ALIM, HALO, VTUS

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

>>5 Stocks Set to Soar on Bullish Earnings

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Rocket Stocks to Buy for June Gains

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Halozyme Therapeutics

Halozyme Therapeutics (HALO), a biopharmaceutical company, researches, develops and commercializes human enzymes. This stock closed up 3.3% to $9.48 in Tuesday's trading session.

Tuesday's Range: $9.15-$9.49

52-Week Range: $5.88-$18.18

Tuesday's Volume: 1.43 million

Three-Month Average Volume: 2.40 million

From a technical perspective, HALO spiked notably higher here right above some near-term support at $8.75 with lighter-than-average volume. This spike higher on Tuesday is quickly pushing shares of HALO within range of triggering a major breakout trade. That trade will hit if HALO manages to take out Tuesday's intraday high of $9.49 to some more key overhead resistance at $9.75 with high volume.

Traders should now look for long-biased trades in HALO as long as it's trending above Tuesday's low of $9.15 or above more near-term support at $8.75 and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.40 million shares. If that breakout begins soon, then HALO will set up to re-fill some of its previous gap-down-day zone from April that started just above $12.

Ventrus Biosciences

Ventrus Biosciences (VTUS), a development-stage specialty pharmaceutical company, focuses on the late-stage development and commercialization of gastrointestinal products in the U.S. This stock closed up 1.1% to $1.38 a share in Tuesday's trading session.

Tuesday's Range: $1.29-$1.41

52-Week Range: $0.85-$4.69

Tuesday's Volume: 565,000

Three-Month Average Volume: 601,191

From a technical perspective, VTUS spiked modestly higher here right above some near-term support around $1.25 with decent upside volume. This stock has been uptrending strong for the last few weeks, with shares moving higher from its low of 85 cents per share to its recent high of $1.46. During that uptrend, shares of VTUS have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of VTUS within range of triggering a major breakout trade. That trade will hit if VTUS manages to take out some key overhead resistance levels at $1.46 to $1.47 and then above $1.50 with high volume.

Traders should now look for long-biased trades in VTUS as long as it's trending above some near-term support around $1.25 and then once it sustains a move or close above those breakout levels with volume that hits near or above 601,191 shares. If that breakout triggers soon, then VTUS will set up to re-test or possibly take out its next major overhead resistance level at its gap-down-day high from February at $1.78. Any high-volume move above $1.78 will then give VTUS a chance to re-fill some of its previous gap-down-day zone that started just above $4.50.

Alimera Sciences

Alimera Sciences (ALIM), a biopharmaceutical company, is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. This stock closed up 1.8% to $5.66 in Tuesday's trading session.

Tuesday's Range: $5.48-$5.69

52-Week Range: $1.65-$8.44

Tuesday's Volume: 30,000

Three-Month Average Volume: 206,623

From a technical perspective, ALIM spiked modestly higher here right above some near-term support at $5.12 with lighter-than-average volume. This stock recently formed a triple bottom chart pattern at $5, $5 and $5.12. Following that bottom, shares of ALIM have started to spike higher and move within range of triggering a near-term breakout trade. That trade will hit if ALIM manages to take out some near-term overhead resistance levels at $5.71 to its 50-day moving average at $5.98 and then once it clears more key overhead resistance at $6.13 with high volume.

Traders should now look for long-biased trades in ALIM as long as it's trending above those triple bottom support levels and then once it sustains a move or close above those breakout levels volume that hits near or above 206,623 shares. If that breakout materializes soon, then ALIM will set up to re-test or possibly take out its next major overhead resistance levels at $7 to $7.50.

To see more stocks that are making notable moves higher, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com.

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zeros